Your offer for up to $50 OFF

This copay assistance offer may be applied for instant savings up to $50 toward out-of-pocket expenses for up to 30 capsules of Vyvanse. This offer is not valid for prescriptions covered by or submitted for reimbursement under Medicaid, Medicare, or similar federal or state programs including any state medical pharmaceutical assistance program or for residents of Massachusetts.

PATIENT INSTRUCTIONS: This copay assistance offer is provided to you as a service by your prescriber and Shire. Present this copay assistance offer to your pharmacist along with your insurance card and a signed prescription for instant savings that can be applied toward out-of-pocket for up to 30 capsules of Vyvanse. This copay assistance offer may not be redeemed for cash. Follow the dosage instructions given by the doctor. One copay assistance offer per person. Patient questions, please call 1-866-441-3469.

PHARMACIST INSTRUCTIONS: This copay assistance offer must be accompanied by a signed prescription for Vyvanse. Prescriber ID# required on prescription. Please submit the copay authorized by the patient's primary insurance as a secondary transaction to OPUS Health. For self-pay patients, please submit the claim at U & C. Patient can use the copay assistance offer toward out-of-pocket expenses up to $50 toward one prescription for up to 30 capsules of Vyvanse. This copay assistance offer is valid for up to $50 off one prescription of Vyvanse of any dosage strength or combination of dosage strengths as prescribed. Claims should not be submitted for reimbursement to any public payor (ie. Medicare/Medicaid). Pharmacist questions, please call OPUS Health at 1-800-364-4767.

Program expires 12/31/09. Program managed by OPUS Health and P.S.K.W. & Associates on behalf of Shire US Inc. The parties reserve the right to amend or end these programs at any time. Product dispensed pursuant to program rules and federal and state laws. Not valid if reproduced. Void where prohibited by law.

Your offer for up to $50 OFF

Important Safety Information

Vyvanse is indicated for the treatment of ADHD. Efficacy based on two controlled trials in children aged 6 to 12 and one controlled trial in adults.

Tell the doctor about any heart conditions, including structural abnormalities, that you, your child, or a family member, may have. Inform the doctor immediately if you or your child develops symptoms that suggest heart problems, such as chest pain or fainting.

Vyvanse should not be taken if you or your child has advanced disease of the blood vessels (arteriosclerosis); symptomatic heart disease; moderate to severe high blood pressure; overactive thyroid gland (hyperthyroidism); known allergy or unusual reactions to drugs called sympathomimetic amines (for example, pseudoephedrine); seizures; glaucoma; a history of problems with alcohol or drugs; agitated states; taken a monoamine oxidase inhibitor (MAOI) within the last 14 days.

Tell the doctor before taking Vyvanse if you or your child is being treated for or has symptoms of depression (sadness, worthlessness, or hopelessness) or bipolar disorder; has abnormal thought or visions, hears abnormal sounds, or has been diagnosed with psychosis; has had seizures or abnormal EEGs; has or has had high blood pressure; exhibits aggressive behavior or hostility. Tell the doctor immediately if you or your child develops any of these conditions or symptoms while taking Vyvanse.

Abuse of amphetamines may lead to dependence. Misuse of amphetamine may cause sudden death and serious cardiovascular adverse events. These events have also been reported rarely with amphetamine use.

Talk to your health care provider if your child experiences slowing of growth (height and weight). Children should have their height and weight checked periodically while taking Vyvanse. Your health care provider may stop Vyvanse treatment if a problem is found during these check-ups.

Vyvanse was generally well tolerated in clinical studies. The most common side effects reported in studies of Vyvanse were: children–decreased appetite, difficulty falling asleep, stomachache, and irritability; adult–decreased appetite, difficulty falling asleep, and dry mouth.

Aggression, new abnormal thoughts/behaviors, mania, growth suppression, worsening of motion or verbal tics, and Tourette’s syndrome have been associated with use of drugs of this type. Tell the doctor if you or your child has blurred vision while taking Vyvanse.

Please see Full Prescribing Information, including Medication Guide.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.